ArticleAllergy2025

Two-Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti-inflammatory Drug-Exacerbated Respiratory Disease.

H B E Elzinga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.